ישראל - עברית - Ministry of Health

roche pharmaceuticals (israel) ltd - epoetin beta - תמיסה להזרקה - epoetin beta 4000 iu / 0.3 ml - erythropoietin - erythropoietin - treatment of anemia associated with chronic renal failure (renal anemia) in patients on dialysis. treatment of symptomatic renal anemia in patients not yet undergoing dialysis. increasing the yield of autologous blood from patients in a pre-donation program. its use in this indication must be balanced against the reported increased risk of thromboembolic events. treatment should only be given to patients with moderate anemia (hb 10-13 g/dl (6.21- 8.07 mmol/l) no iron deficiency) or when blood conserving procedures are not available or insufficient when the scheduled major elective surgery requires a large volume of blood (4 or more units of blood for females or 5 or more units for males). treatment of anemia in adult patients with solid tumors and treated with platinum-based chemotherapy prone to induce anemia (cisplatin 75 mg/m2/cycle carboplatin: 350 mg/m2/cycle). treatment of anemia in adult patients with multiple myeloma low grade non-hodgkin's lymphoma or chronic lymphocytic leukemia who have a relative

ישראל - עברית - Ministry of Health

roche pharmaceuticals (israel) ltd - epoetin beta - תמיסה להזרקה - epoetin beta 6000 iu / 0.3 ml - erythropoietin - erythropoietin - treatment of anemia associated with chronic renal failure (renal anemia) in patients on dialysis. treatment of symptomatic renal anemia in patients not yet undergoing dialysis. increasing the yield of autologous blood from patients in a pre-donation program. its use in this indication must be balanced against the reported increased risk of thromboembolic events. treatment should only be given to patients with moderate anemia (hb 10-13 g/dl (6.21- 8.07 mmol/l) no iron deficiency) or when blood conserving procedures are not available or insufficient when the scheduled major elective surgery requires a large volume of blood (4 or more units of blood for females or 5 or more units for males). treatment of anemia in adult patients with solid tumors and treated with platinum-based chemotherapy prone to induce anemia (cisplatin 75 mg/m2/cycle carboplatin: 350 mg/m2/cycle). treatment of anemia in adult patients with multiple myeloma low grade non-hodgkin's lymphoma or chronic lymphocytic leukemia who have a relative

ישראל - עברית - Ministry of Health

roche pharmaceuticals (israel) ltd - epoetin beta - תמיסה להזרקה - epoetin beta 30000 iu / 0.6 ml - erythropoietin - erythropoietin - treatment of anemia associated with chronic renal failure (renal anemia) in patients on dialysis. treatment of symptomatic renal anemia in patients not yet undergoing dialysis. increasing the yield of autologous blood from patients in a pre-donation program. its use in this indication must be balanced against the reported increased risk of thromboembolic events. treatment should only be given to patients with moderate anemia (hb 10-13 g/dl (6.21- 8.07 mmol/l) no iron deficiency) or when blood conserving procedures are not available or insufficient when the scheduled major elective surgery requires a large volume of blood (4 or more units of blood for females or 5 or more units for males). treatment of anemia in adult patients with solid tumors and treated with chemotherapy . treatment of anemia in adult patients with multiple myeloma low grade non-hodgkin's lymphoma or chronic lymphocytic leukemia who have a relative erythropoietin deficiency and are receiving anti-tumor therapy. deficiency is defined as an i

ישראל - עברית - Ministry of Health

taro pharmaceutical industries ltd - glyceryl trinitrate 1 mg/ml - solution for infusion - glyceryl trinitrate - nitroglycerin is indicated for: 1. control of hypertension during cardiac surgery. 2. unresponsive congestive heart failure associated with acute myocardial infarction. 3. treatment of anginal pectoris in hospitalised patients who have not responded to organic nitrates and/or beta blockers. 4. maintenance of controlles hypotension during surgical procedurs.

ישראל - עברית - Ministry of Health

novartis pharma services ag - glyceryl trinitrate 25 mg/patch - patches - glyceryl trinitrate - prophylaxis of angina pectoris.

ישראל - עברית - Ministry of Health

novartis pharma services ag - glyceryl trinitrate 25 mg/patch - patches - glyceryl trinitrate - prophylaxis of angina pectoris.

ישראל - עברית - Ministry of Health

novartis pharma services ag - glyceryl trinitrate 50 mg/patch - patches - glyceryl trinitrate - prophylaxis of angina pectoris.

ישראל - עברית - Ministry of Health

novartis pharma services ag - glyceryl trinitrate 50 mg/patch - patches - glyceryl trinitrate - prophylaxis of angina pectoris.

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - glyceryl trinitrate 18.7 mg - patches - glyceryl trinitrate - prophylaxis of angina pectoris alone or in combination with other anti-anginal therapy.

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - glyceryl trinitrate 37.4 mg - patches - glyceryl trinitrate - prophylaxis of angina pectoris alone or in combination with other anti-anginal therapy.